Larson Financial Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $61.2K | Buy |
1,593
+953
| +149% | +$36.6K | ﹤0.01% | 998 |
|
2025
Q1 | $24.8K | Sell |
640
-215
| -25% | -$8.34K | ﹤0.01% | 1276 |
|
2024
Q4 | $28.9K | Sell |
855
-952
| -53% | -$32.2K | ﹤0.01% | 1082 |
|
2024
Q3 | $73.9K | Buy |
1,807
+1,519
| +527% | +$62.1K | ﹤0.01% | 791 |
|
2024
Q2 | $11.1K | Sell |
288
-797
| -73% | -$30.6K | ﹤0.01% | 1227 |
|
2024
Q1 | $46.5K | Buy |
1,085
+200
| +23% | +$8.58K | ﹤0.01% | 707 |
|
2023
Q4 | $32.8K | Hold |
885
| – | – | ﹤0.01% | 732 |
|
2023
Q3 | $32.1K | Buy |
885
+647
| +272% | +$23.5K | ﹤0.01% | 716 |
|
2023
Q2 | $8.5K | Sell |
238
-390
| -62% | -$13.9K | ﹤0.01% | 980 |
|
2023
Q1 | $22.3K | Buy |
628
+390
| +164% | +$13.9K | ﹤0.01% | 714 |
|
2022
Q4 | $8.35K | Buy |
238
+1
| +0.4% | +$35 | ﹤0.01% | 915 |
|
2022
Q3 | $7K | Buy |
237
+1
| +0.4% | +$30 | ﹤0.01% | 875 |
|
2022
Q2 | $13K | Buy |
236
+2
| +0.9% | +$110 | ﹤0.01% | 637 |
|
2022
Q1 | $13K | Buy |
234
+4
| +2% | +$222 | ﹤0.01% | 593 |
|
2021
Q4 | $13K | Buy |
230
+2
| +0.9% | +$113 | ﹤0.01% | 616 |
|
2021
Q3 | $11K | Buy |
228
+3
| +1% | +$145 | ﹤0.01% | 577 |
|
2021
Q2 | $11K | Buy |
225
+3
| +1% | +$147 | ﹤0.01% | 533 |
|
2021
Q1 | $10K | Sell |
222
-13
| -6% | -$586 | ﹤0.01% | 542 |
|
2020
Q4 | $11K | Buy |
235
+5
| +2% | +$234 | ﹤0.01% | 479 |
|
2020
Q3 | $11K | Buy |
230
+41
| +22% | +$1.96K | ﹤0.01% | 422 |
|
2020
Q2 | $10K | Buy |
189
+3
| +2% | +$159 | ﹤0.01% | 396 |
|
2020
Q1 | $9K | Buy |
186
+2
| +1% | +$97 | 0.01% | 306 |
|
2019
Q4 | $11K | Buy |
184
+2
| +1% | +$120 | 0.01% | 286 |
|
2019
Q3 | $10K | Buy |
182
+2
| +1% | +$110 | 0.01% | 307 |
|
2019
Q2 | $9K | Buy |
180
+2
| +1% | +$100 | 0.01% | 257 |
|
2019
Q1 | $9K | Buy |
178
+3
| +2% | +$152 | 0.01% | 245 |
|
2018
Q4 | $8K | Buy |
+175
| New | +$8K | 0.01% | 240 |
|